» Authors » Christoph Schankin

Christoph Schankin

Explore the profile of Christoph Schankin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 2062
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasiri D, Hani L, Goldberg J, Petutschnigg T, Dobrocky T, Schar R, et al.
AJNR Am J Neuroradiol . 2025 Jan; PMID: 39788630
Background And Purpose: In patients diagnosed with spontaneous intracranial hypotension (SIH), microspurs are considered the culprit lesion in most ventral dural leaks (type I). The imaging characteristics of discogenic spurs,...
2.
Riederer F, Beiersdorf J, Lang C, Pirker-Kees A, Klein A, Scutelnic A, et al.
Clin Neurophysiol . 2024 Feb; 160:113-120. PMID: 38422969
Objective: Cortical spreading depolarization is highly conserved among the species. It is easily detectable in direct cortical surface recordings and has been recorded in the cortex of humans with severe...
3.
Diener H, Kropp P, Dresler T, Evers S, Forderreuther S, Gaul C, et al.
Neurol Res Pract . 2022 Aug; 4(1):37. PMID: 36031642
Introduction: Chronic headache due to the overuse of medication for the treatment of migraine attacks has a prevalence of 0.5-2.0%. This guideline provides guidance for the management of medication overuse...
4.
Jesse C, Hani L, Fung C, Ulrich C, Schar R, Dobrocky T, et al.
J Neurol . 2022 Jun; 269(10):5466-5473. PMID: 35701531
Objective: Spontaneous intracranial hypotension (SIH), which is often caused by a spinal cerebrospinal fluid leak, is an important cause of disabling headaches. Many patients report devastating changes in their quality...
5.
Dobrocky T, Nicholson P, Hani L, Mordasini P, Krings T, Brinjikji W, et al.
Lancet Neurol . 2022 Mar; 21(4):369-380. PMID: 35227413
Spontaneous intracranial hypotension is caused by loss of CSF at the level of the spine. The most frequent symptom of this disorder is orthostatic headache, with the headache worsening in...
6.
Zecca C, Cargnin S, Schankin C, Giannantoni N, Viana M, Maraffi I, et al.
Eur J Neurol . 2021 Dec; 29(4):1209-1217. PMID: 34965002
Background And Purpose: Erenumab (ERE) is the first anticalcitonin gene-related peptide receptor monoclonal antibody approved for migraine prevention. A proportion of patients do not adequately respond to ERE. Methods: Prospective...
7.
Puledda F, Vandenbussche N, Moreno-Ajona D, Eren O, Schankin C, Goadsby P
Br J Ophthalmol . 2021 Oct; 106(9):1318-1324. PMID: 34656983
Aims: To gather information on useful medications to treat visual snow syndrome (VSS) as well as to validate an instrument to assess its clinical severity and the course of the...
8.
Messmer A, Que Y, Schankin C, Banz Y, Bacher U, Novak U, et al.
Crit Care Explor . 2021 Oct; 3(10):e0552. PMID: 34651139
No abstract available.
9.
Messmer A, Que Y, Schankin C, Banz Y, Bacher U, Novak U, et al.
Wien Klin Wochenschr . 2021 Oct; 133(23-24):1318-1325. PMID: 34613477
Chimeric antigen receptor (CAR) T‑cells are genetically engineered to give T‑cells the ability to attack specific cancer cells, and to improve outcome of patients with refractory/relapsed aggressive B‑cell malignancies. To...
10.
Pohl H, Andree C, Biethahn S, Emmenegger M, Flugel D, Jung H, et al.
Ther Umsch . 2021 Aug; 78(7):341-348. PMID: 34427110
Smarter Medicine in Headache Care - presentation and discussion of 5 recommendations An unequivocal headache diagnosis cannot always be made. The lack of diagnostic tests able to prove primary headaches...